These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29439980)

  • 41. The in vitro, in vivo antifungal activity and the action mode of Jelleine-I against Candida species.
    Jia F; Wang J; Peng J; Zhao P; Kong Z; Wang K; Yan W; Wang R
    Amino Acids; 2018 Feb; 50(2):229-239. PubMed ID: 29101485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design, synthesis and evaluation of benzoheterocycle analogues as potent antifungal agents targeting CYP51.
    Zhao S; Wei P; Wu M; Zhang X; Zhao L; Jiang X; Hao C; Su X; Zhao D; Cheng M
    Bioorg Med Chem; 2018 Jul; 26(12):3242-3253. PubMed ID: 29748145
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design, synthesis and evaluation of aromatic heterocyclic derivatives as potent antifungal agents.
    Zhao S; Zhang X; Wei P; Su X; Zhao L; Wu M; Hao C; Liu C; Zhao D; Cheng M
    Eur J Med Chem; 2017 Sep; 137():96-107. PubMed ID: 28558334
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Semisynthesis and Biological Evaluation of Xanthone Amphiphilics as Selective, Highly Potent Antifungal Agents to Combat Fungal Resistance.
    Lin S; Sin WLW; Koh JJ; Lim F; Wang L; Cao D; Beuerman RW; Ren L; Liu S
    J Med Chem; 2017 Dec; 60(24):10135-10150. PubMed ID: 29155590
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel Hit Compounds as Putative Antifungals: The Case of
    Kritsi E; Matsoukas MT; Potamitis C; Detsi A; Ivanov M; Sokovic M; Zoumpoulakis P
    Molecules; 2019 Oct; 24(21):. PubMed ID: 31731542
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The in vitro effects of interferon-gamma, alone or in combination with amphotericin B, tested against the pathogenic fungi Candida albicans and Aspergillus fumigatus.
    El-Khoury M; Ligot R; Mahoney S; Stack CM; Perrone GG; Morton CO
    BMC Res Notes; 2017 Aug; 10(1):364. PubMed ID: 28764751
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Unique Dual-Readout High-Throughput Screening Assay To Identify Antifungal Compounds with Aspergillus fumigatus.
    Beattie SR; Krysan DJ
    mSphere; 2021 Aug; 6(4):e0053921. PubMed ID: 34406854
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combinatorial strategies for combating invasive fungal infections.
    Spitzer M; Robbins N; Wright GD
    Virulence; 2017 Feb; 8(2):169-185. PubMed ID: 27268286
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo imaging of disseminated murine Candida albicans infection reveals unexpected host sites of fungal persistence during antifungal therapy.
    Jacobsen ID; Lüttich A; Kurzai O; Hube B; Brock M
    J Antimicrob Chemother; 2014 Oct; 69(10):2785-96. PubMed ID: 24951534
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus.
    Lewis RE; Liao G; Hou J; Prince RA; Kontoyiannis DP
    J Antimicrob Chemother; 2011 Jun; 66(6):1324-31. PubMed ID: 21486855
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparative study of the post-antifungal effect (PAFE) of amphotericin B, triazoles and echinocandins on Aspergillus fumigatus and Candida albicans.
    Manavathu EK; Ramesh MS; Baskaran I; Ganesan LT; Chandrasekar PH
    J Antimicrob Chemother; 2004 Feb; 53(2):386-9. PubMed ID: 14729762
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Are the Statins promising antifungal agents against invasive candidiasis?
    Lima WG; Alves-Nascimento LA; Andrade JT; Vieira L; de Azambuja Ribeiro RIM; Thomé RG; Dos Santos HB; Ferreira JMS; Soares AC
    Biomed Pharmacother; 2019 Mar; 111():270-281. PubMed ID: 30590315
    [TBL] [Abstract][Full Text] [Related]  

  • 54. FR209602 and related compounds, novel antifungal lipopeptides from coleophoma crateriformis no. 738. II. In vitro and in vivo antifungal activity.
    Kanasaki R; Abe F; Furukawa S; Yoshikawa K; Fujie A; Hino M; Hashimoto S; Hori Y
    J Antibiot (Tokyo); 2006 Mar; 59(3):145-8. PubMed ID: 16724454
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression, purification and in vitro antifungal activity of acidic mammalian chitinase against Candida albicans, Aspergillus fumigatus and Trichophyton rubrum strains.
    Chen L; Shen Z; Wu J
    Clin Exp Dermatol; 2009 Jan; 34(1):55-60. PubMed ID: 19076793
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel conformationally restricted triazole derivatives with potent antifungal activity.
    Wang W; Wang S; Liu Y; Dong G; Cao Y; Miao Z; Yao J; Zhang W; Sheng C
    Eur J Med Chem; 2010 Dec; 45(12):6020-6. PubMed ID: 20950895
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel alkylated azoles as potent antifungals.
    Shrestha SK; Garzan A; Garneau-Tsodikova S
    Eur J Med Chem; 2017 Jun; 133():309-318. PubMed ID: 28395217
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination of fluconazole with non-antifungal agents: a promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery.
    Liu S; Hou Y; Chen X; Gao Y; Li H; Sun S
    Int J Antimicrob Agents; 2014 May; 43(5):395-402. PubMed ID: 24503221
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and antifungal activity of novel thiazole-containing triazole antifungals.
    Tsuruoka A; Kaku Y; Kakinuma H; Tsukada I; Yanagisawa M; Naito T
    Chem Pharm Bull (Tokyo); 1997 Jul; 45(7):1169-76. PubMed ID: 9246751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Toxicity of a Novel Antifungal Compound Is Modulated by Endoplasmic Reticulum-Associated Protein Degradation Components.
    Raj S; Krishnan K; Askew DS; Helynck O; Suzanne P; Lesnard A; Rault S; Zeidler U; d'Enfert C; Latgé JP; Munier-Lehmann H; Saveanu C
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1438-49. PubMed ID: 26666917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.